Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash University, 381 Royal Parade, Parkville, 3052, Australia,
Int J Clin Pharm. 2013 Dec;35(6):1152-60. doi: 10.1007/s11096-013-9839-z. Epub 2013 Aug 23.
There is a risk that medicines can be dispensed into dose administration aids (DAAs), inaccurately or unsuitably. Quality improvement interventions (QIIs) may target this pharmacy medicine supply service and reduce the occurrence of these dispensing errors. In turn, medicine administration can improve in nursing homes (NHs) that use these devices.
To develop, introduce and evaluate the potential of a QII to improve DAA medicine supply.
Fourteen Victorian community pharmacies and 45 NHs.
A QII was developed using findings from three focus groups with 13 participants involved with DAAs at community pharmacies and NHs. The intervention was introduced to community pharmacies and NHs via a pharmacist-facilitated education session; attendees completed an evaluation questionnaire.
Potential usefulness and effectiveness of the QII at improving DAA supply and reducing dispensing errors.
The QII was titled: 'Be alert and work together for medicine safety, DAA incident awareness toolkit'. Four-hundred and thirty-five questionnaires were returned (85.0 % response rate). Respondents believed the intervention had the potential to improve pharmacy medicine supply or NH medicine administration involving DAAs 'very' (47.3 % of responses) or 'extremely well' (23.4 %). The intervention had the potential to reduce the occurrence of DAA dispensing errors 'very' (49.6 %) or 'extremely well' (20.5 %).
A stakeholder informed QII was perceived to have the potential to improve DAA medicine supply from community pharmacies to NHs and reduce the occurrence of dispensing errors found within them. Future quantitative evaluation of the intervention is required.
药品可能会被错误或不适当地配入给药辅助器具（DAAs）中，存在这种风险。质量改进干预措施（QII）可能针对该药房药品供应服务，并减少这些配药错误的发生。反过来，使用这些设备的养老院（NHs）的药物管理也会得到改善。
开发、引入并评估一项 QII 改善 DAA 药品供应的潜力。
14 家维多利亚社区药房和 45 家 NHs。
使用来自三个焦点小组的结果（共 13 名参与者参与社区药房和 NHs 的 DAA），开发了一项 QII。通过药剂师协助的教育会议向社区药房和 NHs 引入干预措施；参与者完成了一份评估问卷。
QII 在改善 DAA 供应和减少配药错误方面的潜在有用性和有效性。
该 QII 名为“保持警惕，共同保障药物安全，DAA 事故意识工具包”。共收回 435 份问卷（85.0%的回复率）。受访者认为，该干预措施有可能“非常”（47.3%的回应）或“极其”（23.4%）改善药房药品供应或涉及 DAA 的 NH 药物管理。该干预措施有可能“非常”（49.6%）或“极其”（20.5%）降低 DAA 配药错误的发生。
一项由利益相关者参与制定的 QII 被认为有可能改善社区药房向 NHs 的 DAA 药品供应，并减少其中发生的配药错误。需要对该干预措施进行未来的定量评估。
